Records containing: Lymphoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-12-16Precision Physical Exercise for Personalized Onco-Hematology.
-
CLINICAL_TRIALS study record update · 2025-12-15Application of Telemedicine to the Management of Aggressive Lymphomas: a Regional Comparative Study
-
CLINICAL_TRIALS study record update · 2025-12-15Pediatric and Young Adult Leukemia Adoptive Therapy (PLAT)-05: A Phase 1 Feasibility and Safety Study of Dual Specificity CD19 and CD22 CAR-T Cell Immunotherapy for CD19+CD22+ Leukemia
-
CLINICAL_TRIALS study record update · 2025-12-15A Pilot Study Evaluating Mosunetuzumab for Clearance of Detectable Minimal Residual Disease in Chronic Lymphocytic Leukemia
-
CLINICAL_TRIALS study record update · 2025-12-08A Phase I Study of Autologous Activated T-cells Targeting the CD19 Antigen and Containing the Inducible Caspase 9 Safety Switch in Subjects With Relapsed/Refractory B-cell Lymphoma
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-12-05A Phase I/II Study of Neratinib in Pediatric Patients With Relapsed or Refractory Solid Tumors
-
CLINICAL_TRIALS study record update · 2025-12-04A Phase I Study of Bendamustine and Melphalan Conditioning and Autologous Stem Cell Transplantation for Treatment of Multiple Myeloma and Relapsed/Refractory B-cell Lymphoma in Elderly Patients
-
CLINICAL_TRIALS study record update · 2025-12-02PET-CT Imaging Findings and Metabolic Parameters in Elderly Patients With Lymphoma
-
CLINICAL_TRIALS study record update · 2025-11-26Liquid Biopsy Evaluation and Repository Development at Princess Margaret
-
CLINICAL_TRIALS study record update · 2025-11-24DETERMINE (Determining Extended Therapeutic Indications for Existing Drugs in Rare Molecularly Defined Indications Using a National Evaluation Platform Trial): An Umbrella-Basket Platform Trial to Evaluate the Efficacy of Targeted Therapies in Rare Adult, Paediatric and Teenage/Young Adult (TYA) Cancers With Actionable Genomic Alterations, Including Common Cancers With Rare Actionable Alterations. Treatment Arm 01: Alectinib in Adult, Paediatric and Teenage/Young Adult Patients With ALK Positive Cancers
-
CLINICAL_TRIALS study record update · 2025-11-19A Phase 1/2, Open-Label, Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Activity Study of Repotrectinib in Pediatric and Young Adult Subjects With Advanced or Metastatic Malignancies Harboring ALK, ROS1, NTRK1-3 Alterations
-
CLINICAL_TRIALS study record update · 2025-11-18Molecular Characterization of Solid Tumors and Lymphomas to Optimize the Drug Development Process and Patients Enrollment in Early Phase Clinical Trials
-
CLINICAL_TRIALS study record update · 2025-11-18Prospective Observational Study Investigating the Cardiotoxicity of Anthracyclines in Patients With Diffuse Large B-Cell
-
CLINICAL_TRIALS study record update · 2025-11-10Neurocognitive Outcomes After Whole Brain Radiation Therapy for Hematologic Malignancies
-
CLINICAL_TRIALS study record update · 2025-11-10Cognitive Behavioral Therapy (CBT) Intervention for Cancer Related Fatigue (CRF) in Patients With AML and Lymphoma
-
CLINICAL_TRIALS study record update · 2025-11-04Phase I Study of N-Acetylcysteine to Optimize Metabolic Tumor Microenvironment in CD19 CAR T-cell Therapy in Lymphoma
-
CLINICAL_TRIALS study record update · 2025-10-31Administration of TGF-b Resistant LMP-Specific Cytotoxic T-Lymphocytes to Patients With Relapsed EBV-Positive Lymphoma
-
CLINICAL_TRIALS study record update · 2025-10-31Feasibility and Clinical Utility of Cell-free DNA (cfDNA) in Identifying Actionable Alterations and Minimal Residual Disease for Lymphoma Patients Across Community Centers in Texas
-
CLINICAL_TRIALS study record update · 2025-10-31UNRELATED AND PARTIALLY MATCHED RELATED DONOR PERIPHERAL STEM CELL TRANSPLANTATION WITH Alpha/Beta T CELL AND B CELL DEPLETION FOR PATIENTS WITH HEMATOLOGIC MALIGNANCIES
-
CLINICAL_TRIALS study record update · 2025-10-30Living Well With Lymphoma: Improving Diet Quality to Improve Energy, Sleep and Quality of Life
-
CLINICAL_TRIALS study record update · 2025-10-27REBOUND: REsiliency in Older Adults UNDergoing BOne Marrow Transplant - A Pilot Study of Resiliency Measures in Older Patients Undergoing Allogeneic Blood and Marrow Transplant
-
CLINICAL_TRIALS study record update · 2025-10-27Tissue Procurement For Hematolymphoid Conditions
-
CLINICAL_TRIALS study record update · 2025-10-27Using Game Mechanics to Improve Outcomes Among Stem Cell Transplant Survivors
-
CLINICAL_TRIALS study record update · 2025-10-21Phase I Study of Adoptive Transfer of Autologous T Lymphocytes Engrafted With a Chimeric Antigen Receptor Targeting the Kappa Light Chain of Immunoglobulin Expressed in Patients With CLL, B-Cell Lymphoma or Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2025-10-15A Phase I Study: PET Imaging of Cancer Patients Using [18F] 4-L-Fluoroglutamine (2S,4R)